デフォルト表紙
市場調査レポート
商品コード
1028549

臨床試験キットの市場動向・市場シェア・市場規模の予測 (2021-2028年):サービス (キッティングソリューション・ロジスティクス)・フェーズ (フェーズI・II・III・IV)・地域別

Clinical Trial Kits Market Size, Share & Trends Analysis Report By Service (Kitting Solutions, Logistics), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 110 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.10円
臨床試験キットの市場動向・市場シェア・市場規模の予測 (2021-2028年):サービス (キッティングソリューション・ロジスティクス)・フェーズ (フェーズI・II・III・IV)・地域別
出版日: 2021年09月14日
発行: Grand View Research, Inc.
ページ情報: 英文 110 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床試験キットの市場規模は予測期間中8.5%のCAGRで推移し、2028年には25億米ドルの規模に成長すると予測されています。

臨床試験のグローバル化、遠隔サービスへの需要の高まり、臨床試験の複雑化などの要因が同市場の成長を推進しています。

当レポートでは、世界の臨床試験キットの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、サービス・フェーズ・地域/主要国など各種区分別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場の見通し
  • 普及・成長の見通しマッピング
  • 市場力学
  • 市場分析ツール
  • TAM分析

第4章 COVID-19の影響

第5章 市場分析・予測:サービス別

  • キッティングソリューション
  • ロジスティクス

第6章 市場分析・予測:フェーズ別

  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第7章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業プロファイル
    • Brooks Life Science
    • Q2 solutions
    • Patheon(Thermo Fisher Scientific Inc)
    • Labcorp Drug Development
    • Charles River Laboratories
    • LAbConnect
    • Almac group
    • Precision Medicine Group
    • Cerba research
    • Alpha laboratories
    • Marken a UPS company
    • Clinigen
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 List of Secondary Sources
  • Table 3 Global clinical trial kits market, by region, 2016 & 2028 (USD Million)
  • Table 4 Global clinical trial kits market, by service, 2016 & 2028 (USD Milion)
  • Table 5 Global clinical trial kits market, by phase, 2016 & 2028 (USD Million)
  • Table 6 North America clinical trial kits market, by region, 2016 - 2028 (USD Million)
  • Table 7 North America clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 8 North America clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 9 U.S. clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 10 U.S. clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 11 Canada clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 12 Canada clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 13 Europe clinical trial kits market, by region, 2016 - 2028 (USD Million)
  • Table 14 Europe clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 15 Europe clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 16 U.K. clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 17 U.K. clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 18 Germany clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 19 Germany clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 20 Spain clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 21 Spain clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 22 France clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 23 France clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 24 Italy clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 25 Italy clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 26 Asia Pacific clinical trial kits market, by region, 2016 - 2028 (USD Million)
  • Table 27 Asia Pacific clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 28 Asia Pacific clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 29 China clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 30 China clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 31 India clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 32 India clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 33 Japan clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 34 Japan clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 35 Australia clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 36 Australia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 37 South Korea clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 38 South Korea clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 39 Latin America clinical trial kits market, by region, 2016 - 2028 (USD Million)
  • Table 40 Latin America clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 41 Latin America clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 42 Brazil clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 43 Brazil clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 44 Mexico clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 45 Mexico clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 46 Argentina clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 47 Argentina clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 48 Colombia clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 49 Colombia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 50 MEA clinical trial kits market, by region, 2016 - 2028 (USD Million)
  • Table 51 MEA clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 52 MEA clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 53 South Africa clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 54 South Africa clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 55 Saudi Arabia clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 56 Saudi Arabia clinical trial kits market, by phase, 2016 - 2028 (USD Million)
  • Table 57 UAE clinical trial kits market, by service, 2016 - 2028 (USD Million)
  • Table 58 UAE clinical trial kits market, by phase, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Clinical trial kits snapshot (2020)
  • Fig. 9 Clinical trial kits market segmentation
  • Fig. 10 Clinical trial kits market: Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Companies with affected trials, by size
  • Fig. 19 Affected trials, by study phase
  • Fig. 20 Clinical trial kits market service: Segment dashboard
  • Fig. 21 Clinical trial kits market: Service movement analysis
  • Fig. 22 Kitting solutions market, 2016 - 2028 (USD Million)
  • Fig. 23 Drug kits market, 2016 - 2028 (USD Million)
  • Fig. 24 Sample collection kits market, 2016 - 2028 (USD Million)
  • Fig. 25 Logistics market, 2016 - 2028 (USD Million)
  • Fig. 26 Transportation market, 2016 - 2028 (USD Million)
  • Fig. 27 Warehousing & storage market, 2016 - 2028 (USD Million)
  • Fig. 28 Others market, 2016 - 2028 (USD Million)
  • Fig. 29 Clinical trial kits market phase outlook: Segment dashboard
  • Fig. 30 Clinical trial kits market: Phase movement analysis
  • Fig. 31 Phase I market, 2016 - 2028 (USD Million)
  • Fig. 32 Phase II market, 2016 - 2028 (USD Million)
  • Fig. 33 Phase III market, 2016 - 2028 (USD Million)
  • Fig. 34 Phase IV market, 2016 - 2028 (USD Million)
  • Fig. 35 Regional market: Key takeaways
  • Fig. 36 Regional outlook, 2020 2028
  • Fig. 37 North America market, 2016 - 2028 (USD Million)
  • Fig. 38 U.S. market, 2016 - 2028 (USD Million)
  • Fig. 39 Canada market, 2016 - 2028 (USD Million)
  • Fig. 40 Europe market, 2016 - 2028 (USD Million)
  • Fig. 41 U.K. market, 2016 - 2028 (USD Million)
  • Fig. 42 Germany market, 2016 - 2028 (USD Million)
  • Fig. 43 France market, 2016 - 2028 (USD Million)
  • Fig. 44 Italy market, 2016 - 2028 (USD Million)
  • Fig. 45 Spain market, 2016 - 2028 (USD Million)
  • Fig. 46 Asia Pacific market, 2016 - 2028 (USD Million)
  • Fig. 47 Japan market, 2016 - 2028 (USD Million)
  • Fig. 48 China market, 2016 - 2028 (USD Million)
  • Fig. 49 India market, 2016 - 2028 (USD Million)
  • Fig. 50 Australia market, 2016 - 2028 (USD Million)
  • Fig. 51 South Korea market, 2016 - 2028 (USD Million)
  • Fig. 52 Latin America market, 2016 - 2028 (USD Million)
  • Fig. 53 Brazil market, 2016 - 2028 (USD Million)
  • Fig. 54 Mexico market, 2016 - 2028 (USD Million)
  • Fig. 55 Argentina market, 2016 - 2028 (USD Million)
  • Fig. 56 Colombia market, 2016 - 2028 (USD Million)
  • Fig. 57 MEA market, 2016 - 2028 (USD Million)
  • Fig. 58 South Africa market, 2016 - 2028 (USD Million)
  • Fig. 59 Saudi Arabia market, 2016 - 2028 (USD Million)
  • Fig. 60 UAE market, 2016 - 2028 (USD Million)
目次
Product Code: GVR-4-68039-614-2

Clinical Trial Kits Market Growth & Trends

The global clinical trial kits market size is anticipated to reach USD 2.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.

Remote clinical trial services are becoming increasingly essential in terms of patient retention, satisfaction, and safety. To enhance their capabilities, pharmaceutical companies have created a relationship with global logistics partners to provide direct-to-patient services. These services provide participants with the flexibility and convenience of participating in the trials while remaining at home.

COVID-19 pandemic has affected the market which resulted in slowing down the trial process. The COVID-19 pandemic is rapidly boosting advances in medical practices that allow people to connect with the healthcare system remotely. This effort of examining the patients at their homes has raised interest in at-home sample collection and testing. Such services offer convenience and minimize potential exposure to SARS-CoV-2.

Companies began to move to provide direct-to-consumer testing digital services. More aspects of the testing process, from test ordering to sample collection, are already making their way into patients' homes. Besides, regulatory authorities have instantly given sponsors guidelines to resolve issues that have arisen during ongoing clinical studies. Changes such as the use of telemedicine, the elimination of non-essential visits and laboratory assessments, as well as diagnostic testing and sample collection, have allowed many studies to continue while ensuring patient safety during the pandemic.

Clinical Trial Kits Market Report Highlights

The logistics segment dominated the market and accounted for the largest revenue share of 54.9% in 2020. This is due to the increasing demand for services to simplify the logistics process in clinical trials

The phase III segment dominated the market and accounted for the largest revenue share of 53.4% in 2020 as phase III trials require a large number of participants

North America dominated the market in 2020 owing to favorable government support and the existence of a large number of companies offering innovative services in the U.S.

In Asia Pacific, the market is projected to witness the highest CAGR of 9.9% over the forecast period as the region is continuously growing in terms of clinical trials due to the vast population and developing technology

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Service
    • 1.1.2 Phase
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List Of Secondary Sources
  • 1.8 List Of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective - 1:
    • 1.9.2 Objective - 2:
    • 1.9.3 Objective - 3:
    • 1.9.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Clinical Trial Kits Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Globalization of clinical trials
      • 3.3.1.2 Increasing demand for remote services
      • 3.3.1.3 Rising clinical trial complexity
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Varying regulations in countries
  • 3.4 Clinical Trial Kits Market Analysis Tools
    • 3.4.1 Porter's five forces analysis
    • 3.4.2 PESTEL analysis
    • 3.4.3 Major deals & strategic alliances
      • 3.4.3.1 Acquisitions
      • 3.4.3.2 Partnerships
      • 3.4.3.3 Expansion
      • 3.4.3.4 Product launch
      • 3.4.3.5 Collaboration
  • 3.5 Clinical Trial Kits Market: Total Addressable Market (TAM) Analysis
    • 3.5.1 Market Overview

Chapter 4 Covid-19 Impact

  • 4.1 COVID-19 Impact on the market
  • 4.2 COVID-19 Impact on the logistics
  • 4.3 COVID-19 Pandemic Impact on Clinical Trial Activity
    • 4.3.1 Obstacles in clinical trials
    • 4.3.2 Disrupted clinical trials
      • 4.3.2.1 Companies with Phase I trial disruption
      • 4.3.2.2 Companies with Phase 2 trial disruption
      • 4.3.2.3 Companies with Phase 3 trial disruption

Chapter 5 Clinical Trial Kits Market: Service Segment Analysis

  • 5.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
  • 5.2 Kitting Solutions
    • 5.2.1 Kitting solutions market, 2016 - 2028 (USD Million)
    • 5.2.2 Drug Kits
      • 5.2.2.1 Drug kits market, 2016 - 2028 (USD Million)
    • 5.2.3 Sample Collection Kits
      • 5.2.3.1 Sample collection kits market, 2016 - 2028 (USD Million)
  • 5.3 Logistics
    • 5.3.1 Logistics market, 2016 - 2028 (USD Million)
    • 5.3.2 Transportation
      • 5.3.2.1 Transportation market, 2016 - 2028 (USD Million)
    • 5.3.3 Warehousing & storage
      • 5.3.3.1 Warehousing & storage market, 2016 - 2028 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 Others market, 2016 - 2028 (USD Million)

Chapter 6 Clinical Trial Kits Market: Phase Segment Analysis

  • 6.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
  • 6.2 Phase I
    • 6.2.1 Phase I Market, 2016 - 2028 (USD Million)
  • 6.3 Phase II
    • 6.3.1 Phase II market, 2016 - 2028 (USD Million)
  • 6.4 Phase III
    • 6.4.1 Phase III market, 2016 - 2028 (USD Million)
  • 6.5 Phase IV
    • 6.5.1 Phase IV market, 2016 - 2028 (USD Million)

Chapter 7 Clinical Trial Kits Market: Regional Analysis

  • 7.1 Clinical Trial Kits: Market Share Analysis, 2020 & 2028
  • 7.2 North America
    • 7.2.1 North America clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada clinical trial kits market, 2016 - 2028 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain clinical trial kits market, 2016 - 2028 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Australia clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea clinical trial kits market, 2016 - 2028 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.5.5 Colombia
      • 7.5.5.1 Colombia clinical trial kits market, 2016 - 2028 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia clinical trial kits market, 2016 - 2028 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE clinical trial kits market, 2016 - 2028 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 Brooks Life Science
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Service benchmarking
      • 8.1.1.4 Strategy initiatives
    • 8.1.2 Q2 solutions
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Service benchmarking
      • 8.1.2.4 Strategy initiatives
    • 8.1.3 Patheon (Thermo Fisher Scientific Inc)
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 ServicebBenchmarking
    • 8.1.4 Labcorp Drug Development
      • 8.1.4.1 Company overview
      • 8.1.4.2 financial performance
      • 8.1.4.3 Service benchmarking
      • 8.1.4.4 Strategy initiatives
    • 8.1.5 Charles River Laboratories
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial performance
      • 8.1.5.3 Service benchmarking
    • 8.1.6 LAbConnect
      • 8.1.6.1 Company overview
      • 8.1.6.2 Service Benchmarking
      • 8.1.6.3 Strategy initiatives
    • 8.1.7 Almac group
      • 8.1.7.1 Company overview
      • 8.1.7.2 Service benchmarking
      • 8.1.7.3 Strategy initiatives
    • 8.1.8 Precision Medicine Group
      • 8.1.8.1 Company overview
      • 8.1.8.2 Service benchmarking
      • 8.1.8.3 Strategic initiatives
    • 8.1.9 Cerba research
      • 8.1.9.1 Company overview
      • 8.1.9.2 Service benchmarking
    • 8.1.10 Alpha laboratories
      • 8.1.10.1 Company overview
      • 8.1.10.2 Service benchmarking
    • 8.1.11 Marken a UPS company
      • 8.1.11.1 Company overview
      • 8.1.11.2 Service benchmarking
      • 8.1.11.3 Strategy initiatives
    • 8.1.12 Clinigen
      • 8.1.12.1 Company overview
      • 8.1.12.2 Financial performance
      • 8.1.12.3 Service benchmarking
      • 8.1.12.4 Strategy initiatives